MedTrace Logo

Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery

NCT06745492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2024-12-20

No results posted yet for this study

Summary

This study is a prospective observational study. A total of 54 patients were included in this study. We observed the time from neostigmine administration to TOF ratio of 1.0.

Conditions

  • Recovery Time

Interventions

DRUG

Neostigmine + Glycopyrrolate

a 20 mcg/kg of neostigmine and 4 mcg/kg of glycopyrrolate were administered at a TOF ratio of 0.7.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chang-Hoon Koo · Seoul National University Bundang Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-08-20
Completion
2023-08-25

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06745492 on ClinicalTrials.gov